share_log

6-K: Transaction Notification

6-K: Transaction Notification

交易通知
美股SEC公告 ·  2024/10/17 12:07

Moomoo AI 已提取核心訊息

On October 15, 2024, multiple GSK executives participated in dividend reinvestment through the company's Deferred Annual Bonus Plan. CEO Emma Walmsley acquired the largest position with 7,103 ordinary shares at £15.05 per share, plus an additional 1,907 shares at £14.87.Other significant transactions included Chief Commercial Officer Luke Miels acquiring 8,065 shares at £14.87, and President of Corporate Development David Redfern purchasing 5,312 shares at the same price. Non-Executive Director Dr. Hal Barron acquired 2,916 American Depositary Shares at $39.21.The transactions were executed on both the London Stock Exchange and New York Stock Exchange, demonstrating continued insider confidence in the company. All acquisitions were made through dividend reinvestment programs, including the Deferred Annual Bonus Plan and Performance Share Plan.
On October 15, 2024, multiple GSK executives participated in dividend reinvestment through the company's Deferred Annual Bonus Plan. CEO Emma Walmsley acquired the largest position with 7,103 ordinary shares at £15.05 per share, plus an additional 1,907 shares at £14.87.Other significant transactions included Chief Commercial Officer Luke Miels acquiring 8,065 shares at £14.87, and President of Corporate Development David Redfern purchasing 5,312 shares at the same price. Non-Executive Director Dr. Hal Barron acquired 2,916 American Depositary Shares at $39.21.The transactions were executed on both the London Stock Exchange and New York Stock Exchange, demonstrating continued insider confidence in the company. All acquisitions were made through dividend reinvestment programs, including the Deferred Annual Bonus Plan and Performance Share Plan.
在2024年10月15日，多位GSk高管通過公司的延期年終獎金計劃參與了股息再投資。首席執行官艾瑪·沃爾姆斯利以每股15.05英鎊的價格獲得了最大的頭寸，共計7,103股，此外還以14.87英鎊的價格購買了1,907股。其他重要交易包括首席商業官盧克·米爾斯以14.87英鎊的價格收購了8,065股，以及企業發展總裁大衛·雷德芬以相同價格購買5,312股。非執行董事哈利·巴倫博士收購了2,916股美國存托股票，價格爲39.21美元。這些交易在倫敦證券交易所和紐約證券交易所進行，展示了內部人士對公司的持續信懇智能。所有收購均通過股息再投資計劃進行，包括延期年終獎金計劃和業績股份計劃。
在2024年10月15日，多位GSk高管通過公司的延期年終獎金計劃參與了股息再投資。首席執行官艾瑪·沃爾姆斯利以每股15.05英鎊的價格獲得了最大的頭寸，共計7,103股，此外還以14.87英鎊的價格購買了1,907股。其他重要交易包括首席商業官盧克·米爾斯以14.87英鎊的價格收購了8,065股，以及企業發展總裁大衛·雷德芬以相同價格購買5,312股。非執行董事哈利·巴倫博士收購了2,916股美國存托股票，價格爲39.21美元。這些交易在倫敦證券交易所和紐約證券交易所進行，展示了內部人士對公司的持續信懇智能。所有收購均通過股息再投資計劃進行，包括延期年終獎金計劃和業績股份計劃。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    Medicus Pharma
    MDCX
    -- 3.680
    Scilex Holding
    SCLX
    -- 0.354
    阿瑪琳
    AMRN
    -- 0.612
    賽諾菲安萬特
    SNY
    -- 54.500
    艾伯維公司
    ABBV
    -- 192.870
    解鎖完整榜單
    熱門討論
    特朗普2.0時代開啟，全球市場將如何演變？
    🎙️討論： 1. 關稅政策將如何影響美股、黃金、比特幣等核心資產的走勢？ 2. 在此背景下，有哪些投資機會值得關注？你會如何佈局？ 展开
    MicroStrategy 2024年第4季度業績電話會
    重估中國資產
    繼中國開創性的DeepSeek技術推出之後，華爾街大行重估對中國市場的投資前景。